Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Sigyn Therapeutics, Inc. (SIGY) had Return on Investments of 13.52% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-0.67M |
|
-- |
|
-- |
|
$0.55M |
|
$-0.55M |
|
$-0.12M |
|
$-0.67M |
|
$-0.67M |
|
$-0.67M |
|
$-0.67M |
|
$-0.67M |
|
$-0.67M |
|
$-0.55M |
|
$-0.52M |
|
1.61M |
|
1.61M |
|
$-0.42 |
|
$-0.42 |
|
| Balance Sheet Financials | |
$0.07M |
|
$0.01M |
|
$0.18M |
|
$0.24M |
|
$5.15M |
|
-- |
|
$0.04M |
|
$5.19M |
|
$-4.95M |
|
$-4.95M |
|
$-4.95M |
|
1.60M |
|
| Cash Flow Statement Financials | |
$-0.29M |
|
-- |
|
$0.30M |
|
$0.01M |
|
$0.01M |
|
$0.00M |
|
$0.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.01 |
|
-- |
|
-- |
|
-- |
|
-0.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
13.52% |
|
13.52% |
|
-273.66% |
|
|
Return on Investments |
13.52% |
$-3.08 |
|
$-0.18 |
|
$-0.18 |
|